Merck, Pfizer and AstraZeneca Emerge as Leaders in the 2016 Indegene Worldwide Digital Savvy HCP Study

Jan 25, 2016, 04:00 ET from Indegene

ISELIN, New Jersey, January 25, 2016 /PRNewswire/ --

Indegene, a global healthcare solutions provider to life sciences companies, payers and providers, today revealed the outcomes of a worldwide study on doctors and their digital habits. The study deciphers the most effective channel mix across the US, Japan, China and India, as well as identifies those companies perceived to be leaders by HCPs themselves.

     (Photo: http://photos.prnewswire.com/prnh/20160125/786971)

     (Logo: http://photos.prnewswire.com/prnh/20141208/720248)

"Doctors just don't have the time anymore. Tremendous focus on delivering better health outcomes leaves very little time to spend with the reps. In addition, physician access has changed and doctors expect a better digital experience," said Sanjay Virmani, EVP - Indegene.

The study surveyed over 1600+ doctors of which 85% had over 10 years of experience. 67% of doctors surveyed were specialists. Across markets, HCPs predominately preferred face-to-face interactions, online-detailing, and email. In China, HCPs are 2 times more inclined to online-detailing compared to rep detailing. The US and Japan, were found to be significantly ahead of the curve with regard to using digital to engage their patients. Doctors in China and India seemed comfortable with more than 2-3 text messages and 4 emails in a month, whereas in the US, doctors want face to face, online, app, text and websites detailing once a month.

"Merck, Pfizer and AstraZeneca were seen ahead of the curve in digital engagement with doctors worldwide. GSK, Abbott, Novartis and Sanofi were mentioned for their notable performance on the digital scale," added Virmani.

A complimentary copy of the report can be requested here

About Indegene: 

Indegene (http://www.indegene.com) enables global healthcare organizations address complex challenges by seamlessly integrating analytics, technology, operations and medical expertise and drives better health and business outcomes. Indegene's IP based solutions help clients drive revenues and productivity by making giant leaps in digital transformation, customer engagement, health reform, healthcare cost reduction, and health outcomes improvement.

Indegene works with Fortune 500 global customers including life science organizations, health plans and provider organizations. Indegene's Lifesciences practice delivers Medical and Commercial solutions to global pharmaceutical, biotech and device customers. Indegene's healthcare practice delivers next generation solutions for payers and providers across end-to-end Risk Adjustment, HEDIS/STARS improvement, Population Health Management and Member/Provider Engagement solutions.

For more information, please contact:

For US and Europe:
Ann-Marie Craggan
Email: Ann-Marie.Craggan@indegene.com
Phone: +1 732 750 2901

For Asia Pacific:
Shefali Kotnala
Email: spectrumcommunications@live.in
Phone: +91-9886378407


SOURCE Indegene